NIH-funded research NIH-funded research

Comparing two treatments for severe mitral regurgitation

Official title: Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation: A Comparative Study of Clinical Outcomes, Patient Experiences, and Mechanistic Insights with Multimodality Imaging

Funded at Cedars-Sinai Medical Center · NIH-11135718 · Data updated 2026-11-12

This study is looking at how two different treatments for degenerative mitral regurgitation—one done through a small tube and the other through traditional surgery—affect patients' health and experiences, so we can better understand which option might work best for you over time.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCedars-Sinai Medical Center
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$834,249
NIH project number1R56HL175516-01
Project IDNIH-11135718 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults diagnosed with severe degenerative mitral regurgitation, particularly those over 75 years old.

Less likely to help

Patients with mild mitral regurgitation or those who are not candidates for either treatment option may not benefit from this research.

What this research studies

This research investigates the differences in clinical outcomes and patient experiences between two treatment options for degenerative mitral regurgitation: transcatheter edge-to-edge repair and traditional surgical repair. By following approximately 1,800 patients over a decade, the study aims to gather comprehensive data on the effectiveness, safety, and long-term results of each treatment. Patients will undergo multimodality imaging to assess their heart function and recovery, providing valuable insights into which approach may be more beneficial. The goal is to fill existing knowledge gaps and improve treatment decisions for patients with this condition.

Why it matters

Potential benefit: If successful, this research could lead to improved treatment strategies and better outcomes for patients with degenerative mitral regurgitation.

How similar studies have gone: While there have been advancements in treatment for mitral regurgitation, this research is novel as it aims to directly compare the two main treatment options in a large cohort over an extended period.

Where this research is happening

  • Cedars-Sinai Medical Center
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Gupta, Aakriti — Cedars-Sinai Medical Center
  • Study coordinator: Gupta, Aakriti

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.